[Prospects of Application of Remote Preconditioning at Heart Revascularization]

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Physiology

Background:

• Remote ischemic preconditioning (RIPC) demonstrates cardioprotective effects, including anti-necrotic, antiarrhythmic, and inotropic benefits.
• Clinical trials in adults and children undergoing cardiac surgery have provided evidence for these effects.

Purpose of the Study:

• To address the lack of consensus among cardiologists regarding the impact of RIPC on intraoperative myocardial infarction incidence.
• To investigate the effect of RIPC on postoperative mortality rates.
• To explore the optimal choice of RIPC protocol and its timing before cardiac surgery.

Main Methods:

• Review of existing clinical trials and cardiologists' consensus on remote ischemic preconditioning.
• Analysis of data on intraoperative myocardial infarction and postoperative mortality in cardiac surgery patients.
• Evaluation of different remote ischemic preconditioning protocols and application timings.

Main Results:

• While RIPC exhibits beneficial effects, there is no established consensus on its definitive impact on reducing intraoperative myocardial infarctions.
• The effect of RIPC on postoperative mortality remains a subject of debate within the cardiology community.
• Significant disagreement exists regarding the ideal RIPC protocol and the optimal timing for its administration prior to cardiac surgery.

Conclusions:

• Remote ischemic preconditioning offers potential cardioprotective benefits in cardiac surgery.
• Further research and standardization are needed to clarify the role of RIPC in mitigating myocardial infarction and improving outcomes.
• Consensus on optimal RIPC protocols and timing is crucial for its widespread clinical application.